SCHEMBL12415

SCHEMBL12415

Cc1n[nH]c(C)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17561029 0.73 AKT2 (0.58)
SCHEMBL15555890 0.71
SCHEMBL1197102 0.69
SCHEMBL20844014 0.69
SCHEMBL1205854 0.69
SCHEMBL23240260 0.69
SCHEMBL22339498 0.69
SCHEMBL22421339 0.69
SCHEMBL112351 0.69
SCHEMBL14043820 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117143150-A Preparation method of chiral 2-hydroxyphosphinic oxide and derivative thereof 广西大学 2023-12-01 CN claimed
US-20210253871-A1 CORROSION-RESISTANT CONDUCTIVE STRUCTURE AND CORROSION-RESISTANT COATING COMPOSITION TPK UNIVERSAL SOLUTIONS LIMITED (HK) 2021-08-19 US claimed
CN-111192857-A Corrosion-resistant conductive structure and corrosion-resistant coating composition 宸盛光电有限公司 2020-05-22 CN claimed
WO-2016123627-A1 ISOQUINILINE AND NAPTHALENE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOUNDS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION VANDERBILT UNIVERSITY (US) 2016-08-04 WO claimed
WO-2013037120-A1 LITHIUM CELL HAVING IMPROVED WEIGHT-LOSS CHARACTERISTICS THE GILLETTE COMPANY (US) 2013-03-21 WO claimed
US-20120180309-A1 Lithium Primary Cells THE GILLETTE COMPANY, A DELAWARE CORPORATION 2012-07-19 US claimed
CN-102047465-A Lithium primary cells GILLETTE CO 2011-05-04 CN claimed
EP-2279538-A1 LITHIUM PRIMARY CELLS The Gillette Company (US) 2011-02-02 EP claimed
US-7736697-B2 Atomic layer deposition of tantalum-containing films using surface-activating agents and novel tantalum complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-06-15 US claimed
WO-2009148727-A1 LITHIUM PRIMARY CELLS THE GILLETTE COMPANY (US) 2009-12-10 WO claimed
US-20090297949-A1 Lithium Primary Cells GILLETTE COMPANY, THE 2009-12-03 US claimed
EP-1913173-A2 ATOMIC LAYER DEPOSITION OF TANTALUM-CONTAINING FILMS USING SURFACE-ACTIVATING AGENTS AND NOVEL TANTALUM COMPLEXES E.I.Du pont de nemours and company (US) 2008-04-23 EP claimed
WO-2007019436-A2 ATOMIC LAYER DEPOSITION OF TANTALUM-CONTAINING FILMS USING SURFACE-ACTIVATING AGENTS AND NOVEL TANTALUM COMPLEXES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-02-15 WO claimed
US-20070036894-A1 forming tantalum nitride layer or tantalum silicide layer; purity; low temperature process for forming a high quality, uniform tantalum-containing films; useful in integrated circuits as barrier films E. I. DU PONT DE NEMOURS AND COMPANY 2007-02-15 US claimed
US-5840913-A CATALYTIC N-ALKYLATION OF A PYRAZOLE BY REACTING WITH AN ALCOHOL; LIQUID PHASE; NON-HETEROGENOUS ACID CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1998-11-24 US claimed
US-4321395-A Preparation of acetanilides BASF AKTIENGESELLSCHAFT (DE) 1982-03-23 US claimed
EP-4712961-A2 KRAS G12S AND G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2026-03-25 EP disclosed
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2026-01-27 US disclosed
EP-0007080-A1 Process for the preparation of N-azolylmethyl-substituted haloacetanilides BASF Aktiengesellschaft (DE) 1980-01-23 EP disclosed
US-3957480-A HERBICIDES THE UPJOHN COMPANY (US) 1976-05-18 US disclosed